{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:34:51Z","timestamp":1789176891407,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1MH105178"],"award-info":[{"award-number":["RO1MH105178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00127-019-01810-x","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T13:02:57Z","timestamp":1575378177000},"page":"527-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-9512","authenticated-orcid":false,"given":"Megan S.","family":"Farris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K.","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Addington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"1810_CR1","unstructured":"United Nations Office on Drugs and Crime (2019) World Drug Report 2019: 35 million people worldwide suffer from drug use disorders while only 1 in 7 people receive treatment"},{"issue":"9698","key":"1810_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/s0140-6736(09)61037-0","volume":"374","author":"W Hall","year":"2009","unstructured":"Hall W, Degenhardt L (2009) Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383\u20131391. https:\/\/doi.org\/10.1016\/s0140-6736(09)61037-0","journal-title":"Lancet"},{"issue":"1","key":"1810_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","volume":"269","author":"DJE Lowe","year":"2019","unstructured":"Lowe DJE, Sasiadek JD, Coles AS, George TP (2019) Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci 269(1):107\u2013120. https:\/\/doi.org\/10.1007\/s00406-018-0970-7","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"5","key":"1810_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1503\/jpn.190136","volume":"44","author":"M Leyton","year":"2019","unstructured":"Leyton M (2019) Cannabis legalization: did we make a mistake? Update 2019. J Psychiatry Neurosci 44(5):291\u2013293. https:\/\/doi.org\/10.1503\/jpn.190136","journal-title":"J Psychiatry Neurosci"},{"key":"1810_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117. https:\/\/doi.org\/10.1192\/bjp.184.2.110","journal-title":"Br J Psychiatry"},{"issue":"2","key":"1810_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11920-015-0657-y","volume":"18","author":"C Ksir","year":"2016","unstructured":"Ksir C, Hart CL (2016) Cannabis and psychosis: a critical overview of the relationship. Curr Psychiatry Rep 18(2):12. https:\/\/doi.org\/10.1007\/s11920-015-0657-y","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"1810_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","volume":"195","author":"M Di Forti","year":"2009","unstructured":"Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, Luzi S, Russo M, Paparelli A, Butt A, Stilo SA, Wiffen B, Powell J, Murray RM (2009) High-potency cannabis and the risk of psychosis. Br J Psychiatry 195(6):488\u2013491. https:\/\/doi.org\/10.1192\/bjp.bp.109.064220","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1810_CR8","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","volume":"42","author":"A Marconi","year":"2016","unstructured":"Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E (2016) Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull 42(5):1262\u20131269. https:\/\/doi.org\/10.1093\/schbul\/sbw003","journal-title":"Schizophr Bull"},{"issue":"1","key":"1810_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/schbul\/sbw158","volume":"43","author":"P Fusar-Poli","year":"2017","unstructured":"Fusar-Poli P (2017) The clinical high-risk state for psychosis (CHR-P), version II. Schizophr Bull 43(1):44\u201347. https:\/\/doi.org\/10.1093\/schbul\/sbw158","journal-title":"Schizophr Bull"},{"issue":"2","key":"1810_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/eip.12100","volume":"8","author":"J Addington","year":"2014","unstructured":"Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS (2014) Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry 8(2):104\u2013112. https:\/\/doi.org\/10.1111\/eip.12100","journal-title":"Early Interv Psychiatry"},{"issue":"1","key":"1810_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/acps.12699","volume":"136","author":"R Carney","year":"2017","unstructured":"Carney R, Cotter J, Firth J, Bradshaw T, Yung AR (2017) Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis. Acta Psychiatr Scand 136(1):5\u201315. https:\/\/doi.org\/10.1111\/acps.12699","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1810_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/s0033291715002329","volume":"46","author":"T Kraan","year":"2016","unstructured":"Kraan T, Velthorst E, Koenders L, Zwaart K, Ising HK, van den Berg D, de Haan L, van der Gaag M (2016) Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. Psychol Med 46(4):673\u2013681. https:\/\/doi.org\/10.1017\/s0033291715002329","journal-title":"Psychol Med"},{"key":"1810_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.09.022","volume":"171","author":"KJ Verweij","year":"2017","unstructured":"Verweij KJ, Abdellaoui A, Nivard MG, Sainz Cort A, Ligthart L, Draisma HH, Minica CC, Gillespie NA, Willemsen G, Hottenga JJ, Boomsma DI, Vink JM (2017) Short communication: genetic association between schizophrenia and cannabis use. Drug Alcohol Depend 171:117\u2013121. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.09.022","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1810_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/schbul\/sbn108","volume":"34","author":"C Henquet","year":"2008","unstructured":"Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM (2008) Gene-environment interplay between cannabis and psychosis. Schizophr Bull 34(6):1111\u20131121. https:\/\/doi.org\/10.1093\/schbul\/sbn108","journal-title":"Schizophr Bull"},{"key":"1810_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-12-804791-0.00007-0","volume-title":"The complex connection between cannabis and schizophrenia","author":"B O\u2019Donoghue","year":"2018","unstructured":"O\u2019Donoghue B, McHugh M, Nelson B, McGorry P (2018) Effects of cannabis use in those at ultra-high risk for psychosis. The complex connection between cannabis and schizophrenia. Elsevier, New York, pp 167\u2013181"},{"issue":"7","key":"1810_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0020764018801690","volume":"64","author":"MB Ortiz-Medina","year":"2018","unstructured":"Ortiz-Medina MB, Perea M, Torales J, Ventriglio A, Vitrani G, Aguilar L, Roncero C (2018) Cannabis consumption and psychosis or schizophrenia development. Int J Soc Psychiatry 64(7):690\u2013704. https:\/\/doi.org\/10.1177\/0020764018801690","journal-title":"Int J Soc Psychiatry"},{"key":"1810_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"M Freeman","year":"1950","unstructured":"Freeman M, Tukey J (1950) Transformations related to the angular and the square root. Ann Math Stat 21:607\u2013611","journal-title":"Ann Math Stat"},{"issue":"7414","key":"1810_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins J, Thompson S, Deeks J, Altman D (2003) Measuring inconsistency in meta-analyses. Br Med J 327(7414):557","journal-title":"Br Med J"},{"issue":"2","key":"1810_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","volume":"67","author":"GP Amminger","year":"2010","unstructured":"Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67(2):146\u2013154. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2009.192","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"1810_CR20","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1017\/s0033291712000803","volume":"42","author":"AM Auther","year":"2012","unstructured":"Auther AM, McLaughlin D, Carrion RE, Nagachandran P, Correll CU, Cornblatt BA (2012) Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med 42(12):2485\u20132497. https:\/\/doi.org\/10.1017\/s0033291712000803","journal-title":"Psychol Med"},{"key":"1810_CR21","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/s00406-013-0433-0","volume":"1","author":"J Barglow","year":"2013","unstructured":"Barglow J, Dole T, Birnbaum M (2013) Effectiveness of a community-based early intervention program for psychosis: baseline characteristics and 3-month follow-up. Eur Arch Psychiatry Clin Neurosci 1:S65. https:\/\/doi.org\/10.1007\/s00406-013-0433-0","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"Suppl 2","key":"1810_CR22","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1093\/schbul\/sbr083","volume":"37","author":"A Bechdolf","year":"2011","unstructured":"Bechdolf A, Muller H, Stutzer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brune M, Kruger-Ozgurdal S, Wobrock T, Riedel M, Klosterkotter J (2011) Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophr Bull 37(Suppl 2):S111\u2013S121. https:\/\/doi.org\/10.1093\/schbul\/sbr083","journal-title":"Schizophr Bull"},{"issue":"8","key":"1810_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1017\/s0033291709991711","volume":"40","author":"OJ Bloemen","year":"2010","unstructured":"Bloemen OJ, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L, Dingemans P, Linszen DH, van Amelsvoort TA (2010) White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med 40(8):1297\u20131304. https:\/\/doi.org\/10.1017\/s0033291709991711","journal-title":"Psychol Med"},{"issue":"11","key":"1810_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1017\/s0033291717000319","volume":"47","author":"G Brucato","year":"2017","unstructured":"Brucato G, Masucci MD, Arndt LY, Ben-David S, Colibazzi T, Corcoran CM, Crumbley AH, Crump FM, Gill KE, Kimhy D, Lister A, Schobel SA, Yang LH, Lieberman JA, Girgis RR (2017) Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort. Psychol Med 47(11):1923\u20131935. https:\/\/doi.org\/10.1017\/s0033291717000319","journal-title":"Psychol Med"},{"issue":"11","key":"1810_CR25","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1017\/s0033291715000227","volume":"45","author":"L Buchy","year":"2015","unstructured":"Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J (2015) Substance use in individuals at clinical high risk of psychosis. Psychol Med 45(11):2275\u20132284. https:\/\/doi.org\/10.1017\/s0033291715000227","journal-title":"Psychol Med"},{"issue":"2\u20133","key":"1810_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.schres.2014.04.021","volume":"156","author":"L Buchy","year":"2014","unstructured":"Buchy L, Perkins D, Woods SW, Liu L, Addington J (2014) Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophr Res 156(2\u20133):277\u2013280. https:\/\/doi.org\/10.1016\/j.schres.2014.04.021","journal-title":"Schizophr Res"},{"issue":"2","key":"1810_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00213-013-3157-y","volume":"230","author":"H Bugra","year":"2013","unstructured":"Bugra H, Studerus E, Rapp C, Tamagni C, Aston J, Borgwardt S, Riecher-Rossler A (2013) Cannabis use and cognitive functions in at-risk mental state and first episode psychosis. Psychopharmacology 230(2):299\u2013308. https:\/\/doi.org\/10.1007\/s00213-013-3157-y","journal-title":"Psychopharmacology"},{"issue":"1","key":"1810_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","volume":"65","author":"TD Cannon","year":"2008","unstructured":"Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65(1):28\u201337. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2007.3","journal-title":"Arch Gen Psychiatry"},{"key":"1810_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2016.08.026","volume":"181","author":"R Carney","year":"2017","unstructured":"Carney R, Yung AR, Amminger GP, Bradshaw T, Glozier N, Hermens DF, Hickie IB, Killackey E, McGorry P, Pantelis C, Wood SJ, Purcell R (2017) Substance use in youth at risk for psychosis. Schizophr Res 181:23\u201329. https:\/\/doi.org\/10.1016\/j.schres.2016.08.026","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"1810_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.schres.2014.05.032","volume":"157","author":"EE Carol","year":"2014","unstructured":"Carol EE, Mittal VA (2014) Self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado. Schizophr Res 157(1\u20133):317\u2013318. https:\/\/doi.org\/10.1016\/j.schres.2014.05.032","journal-title":"Schizophr Res"},{"issue":"3","key":"1810_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/070674371005500308","volume":"55","author":"S Dragt","year":"2010","unstructured":"Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH, Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH (2010) Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry 55(3):165\u2013171","journal-title":"Can J Psychiatry"},{"issue":"1","key":"1810_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0447.2011.01763.x","volume":"125","author":"S Dragt","year":"2012","unstructured":"Dragt S, Nieman DH, Schultze-Lutter F, van der Meer F, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, Graf von Reventlow H, French P, Stevens H, Ruhrmann S, Klosterkotter J, Linszen DH (2012) Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand 125(1):45\u201353. https:\/\/doi.org\/10.1111\/j.1600-0447.2011.01763.x","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1810_CR33","first-page":"254","volume":"10","author":"M Gawlowska","year":"2010","unstructured":"Gawlowska M, Rabe-Jablonska J, Pawelczyk T, Pawelczyk A (2010) Assessment of independent risk factors of conversion into psychosis in the ultra-high risk state group of patients (Ocena niezaleznych czynnikow ryzyka konwersji w psychoze w grupie osob z wysokim ryzykiem rozwoju zaburzen psychotycznych). Psychiatr Psychol Klin 10(4):254\u2013266","journal-title":"Psychiatr Psychol Klin"},{"issue":"3","key":"1810_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/eip.12112","volume":"9","author":"KE Gill","year":"2015","unstructured":"Gill KE, Poe L, Azimov N, Ben-David S, Vadhan NP, Girgis R, Moore H, Cressman V, Corcoran CM (2015) Reasons for cannabis use among youths at ultra high risk for psychosis. Early Interv Psychiatry 9(3):207\u2013210. https:\/\/doi.org\/10.1111\/eip.12112","journal-title":"Early Interv Psychiatry"},{"issue":"2","key":"1810_CR35","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.clinph.2015.10.050","volume":"127","author":"F Hagenmuller","year":"2016","unstructured":"Hagenmuller F, Heekeren K, Meier M, Theodoridou A, Walitza S, Haker H, Rossler W, Kawohl W (2016) The Loudness Dependence of Auditory Evoked Potentials (LDAEP) in individuals at risk for developing bipolar disorders and schizophrenia. Clin Neurophysiol 127(2):1342\u20131350. https:\/\/doi.org\/10.1016\/j.clinph.2015.10.050","journal-title":"Clin Neurophysiol"},{"issue":"1\u20132","key":"1810_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.psychres.2006.10.001","volume":"151","author":"K Kristensen","year":"2007","unstructured":"Kristensen K, Cadenhead KS (2007) Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res 151(1\u20132):151\u2013154. https:\/\/doi.org\/10.1016\/j.psychres.2006.10.001","journal-title":"Psychiatry Res"},{"issue":"8","key":"1810_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3109\/00048671003689710","volume":"44","author":"M Machielsen","year":"2010","unstructured":"Machielsen M, van der Sluis S, de Haan L (2010) Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms. Aust N Z J Psychiatry 44(8):721\u2013728. https:\/\/doi.org\/10.3109\/00048671003689710","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"1810_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2010.05.005","volume":"123","author":"E Magaud","year":"2010","unstructured":"Magaud E, Kebir O, Gut A, Willard D, Chauchot F, Olie JP, Kazes M, Krebs MO (2010) Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res 123(1):53\u201358. https:\/\/doi.org\/10.1016\/j.schres.2010.05.005","journal-title":"Schizophr Res"},{"issue":"1","key":"1810_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1751-7893.2011.00299.x","volume":"6","author":"C Marshall","year":"2012","unstructured":"Marshall C, Addington J, Epstein I, Liu L, Deighton S, Zipursky RB (2012) Treating young individuals at clinical high risk for psychosis. Early Interv Psychiatry 6(1):60\u201368. https:\/\/doi.org\/10.1111\/j.1751-7893.2011.00299.x","journal-title":"Early Interv Psychiatry"},{"issue":"4","key":"1810_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1017\/S0033291716002671","volume":"47","author":"M McHugh","year":"2017","unstructured":"McHugh M, McGorry P, Yung A, Lin A, Wood S, Hartmann J, Nelson B (2017) Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis. Psychol Med 47(4):616\u2013626. https:\/\/doi.org\/10.1017\/S0033291716002671","journal-title":"Psychol Med"},{"issue":"6","key":"1810_CR41","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/npp.2013.347","volume":"39","author":"R Mizrahi","year":"2014","unstructured":"Mizrahi R, Kenk M, Suridjan I, Boileau I, George TP, McKenzie K, Wilson AA, Houle S, Rusjan P (2014) Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology 39(6):1479\u20131489. https:\/\/doi.org\/10.1038\/npp.2013.347","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"1810_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.schres.2016.03.015","volume":"174","author":"DH Nieman","year":"2016","unstructured":"Nieman DH, Dragt S, van Duin EDA, Denneman N, Overbeek JM, de Haan L, Rietdijk J, Ising HK, Klaassen RMC, van Amelsvoort T, Wunderink L, van der Gaag M, Linszen DH (2016) COMT Val(158)Met genotype and cannabis use in people with an at Risk Mental State for psychosis: exploring Gene \u00d7 Environment interactions. Schizophr Res 174(1\u20133):24\u201328. https:\/\/doi.org\/10.1016\/j.schres.2016.03.015","journal-title":"Schizophr Res"},{"key":"1810_CR43","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.1016\/S0920-9964(14)70700-5","volume":"1","author":"M Pardo","year":"2014","unstructured":"Pardo M, Tor J, Munoz D, Rodriguez M, Sanchez B, De La Serna E, Matali JL, Sanchez-Gistau V, Carulla M, Baeza I, Dolz M (2014) Cannabis use in a sample of subjects at risk for developing psychosis. Schizophr Res 1:S244\u2013S245","journal-title":"Schizophr Res"},{"issue":"1","key":"1810_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2011.03.022","volume":"129","author":"M Pruessner","year":"2011","unstructured":"Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK (2011) Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res 129(1):29\u201335. https:\/\/doi.org\/10.1016\/j.schres.2011.03.022","journal-title":"Schizophr Res"},{"key":"1810_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12888-014-0361-1","volume":"14","author":"DA Russo","year":"2014","unstructured":"Russo DA, Stochl J, Painter M, Jones PB, Perez J (2014) Substance use in people at clinical high-risk for psychosis. BMC Psychiatry 14:361. https:\/\/doi.org\/10.1186\/s12888-014-0361-1","journal-title":"BMC Psychiatry"},{"issue":"Supplement 1","key":"1810_CR46","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1093\/schbul\/sby016.479","volume":"44","author":"M Serpa","year":"2018","unstructured":"Serpa M, Loch AA, Chianca C, Freitas E, Andrade JC, Alves TM, Hortencio L, Van De Bilt MT, Gattaz W, Rossler W (2018) Illicit drugs use and ultra-high risk (UHR) for psychosis status in a Latin-American sample. Schizophr Bull 44(Supplement 1):S195. https:\/\/doi.org\/10.1093\/schbul\/sby016.479","journal-title":"Schizophr Bull"},{"issue":"2\u20133","key":"1810_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.schres.2009.10.001","volume":"116","author":"AE Simon","year":"2010","unstructured":"Simon AE, Umbricht D (2010) High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 116(2\u20133):168\u2013172. https:\/\/doi.org\/10.1016\/j.schres.2009.10.001","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"1810_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.schres.2016.08.008","volume":"176","author":"HJ Stain","year":"2016","unstructured":"Stain HJ, Bucci S, Baker AL, Carr V, Emsley R, Halpin S, Lewin T, Schall U, Clarke V, Crittenden K, Startup M (2016) A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: the detection and evaluation of psychological therapy (DEPTh) trial. Schizophr Res 176(2\u20133):212\u2013219. https:\/\/doi.org\/10.1016\/j.schres.2016.08.008","journal-title":"Schizophr Res"},{"key":"1810_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","volume":"41","author":"A Stojanovic","year":"2014","unstructured":"Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E, Labad J (2014) Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology 41:23\u201332. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.12.005","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"1810_CR50","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1017\/S0033291714000117","volume":"44","author":"L Valmaggia","year":"2014","unstructured":"Valmaggia L, Day F, Jones C, Bissoli S, Pugh C, Hall D, Bhattacharyya S, Howes O, Stone J, Fusar-Poli P, Byrne M, McGuire P (2014) Cannabis use and transition to psychosis in people at ultra-high risk. Psychol Med 44(12):2503\u20132512. https:\/\/doi.org\/10.1017\/S0033291714000117","journal-title":"Psychol Med"},{"issue":"2","key":"1810_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpsycho.2013.03.012","volume":"88","author":"MJ Van Tricht","year":"2013","unstructured":"Van Tricht MJ, Harmsen EC, Koelman JHTM, Bour LJ, van Amelsvoort TA, Linszen DH, de Haan L, Nieman DH (2013) Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls. Int J Psychophysiol 88(2):149\u2013156. https:\/\/doi.org\/10.1016\/j.ijpsycho.2013.03.012","journal-title":"Int J Psychophysiol"},{"key":"1810_CR52","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1016\/S0920-9964(14)71072-2","volume":"1","author":"PB Ward","year":"2014","unstructured":"Ward PB, Logan S, Scully A, Mathersul D, Loneragan C, Curtis J, Stain HJ, Michie P, Todd J, Schall U, Landon R, Atkinson R (2014) Age of onset and prevalence of substance use in help-seeking ultra-high risk youth are linked to current psychopathology. Schizophr Res 1:S380","journal-title":"Schizophr Res"},{"key":"1810_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/eip.12186","volume":"1","author":"T Winton-Brown","year":"2014","unstructured":"Winton-Brown T, Kumari V, Windler F, Moscoso A, Stone J, Kapur S, McGuire P (2014) Sensory gating, cannabis use and the risk of psychosis. Early Interv Psychiatry 1:60. https:\/\/doi.org\/10.1111\/eip.12186","journal-title":"Early Interv Psychiatry"},{"issue":"4","key":"1810_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s0006-3223(03)00321-4","volume":"54","author":"SW Woods","year":"2003","unstructured":"Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 54(4):453\u2013464. https:\/\/doi.org\/10.1016\/s0006-3223(03)00321-4","journal-title":"Biol Psychiatry"},{"key":"1810_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2017.03.043","volume":"190","author":"J Addington","year":"2017","unstructured":"Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW (2017) Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res 190:90\u201395. https:\/\/doi.org\/10.1016\/j.schres.2017.03.043","journal-title":"Schizophr Res"},{"key":"1810_CR56","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1038\/ncomms8934","volume":"6","author":"GP Amminger","year":"2015","unstructured":"Amminger GP, Schafer MR, Schlogelhofer M, Klier CM, McGorry PD (2015) Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun 6:7934. https:\/\/doi.org\/10.1038\/ncomms8934","journal-title":"Nat Commun"},{"issue":"1","key":"1810_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/acps.12382","volume":"132","author":"AM Auther","year":"2015","unstructured":"Auther AM, Cadenhead KS, Carrion RE, Addington J, Bearden CE, Cannon TD, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Cornblatt BA (2015) Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand 132(1):60\u201368. https:\/\/doi.org\/10.1111\/acps.12382","journal-title":"Acta Psychiatr Scand"},{"issue":"2\u20133","key":"1810_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.schres.2008.08.008","volume":"106","author":"CM Corcoran","year":"2008","unstructured":"Corcoran CM, Kimhy D, Stanford A, Khan S, Walsh J, Thompson J, Schobel S, Harkavy-Friedman J, Goetz R, Colibazzi T, Cressman V, Malaspina D (2008) Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophr Res 106(2\u20133):286\u2013293. https:\/\/doi.org\/10.1016\/j.schres.2008.08.008","journal-title":"Schizophr Res"},{"key":"1810_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12471","author":"G Georgopoulos","year":"2017","unstructured":"Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J (2017) The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry. https:\/\/doi.org\/10.1111\/eip.12471","journal-title":"Early Interv Psychiatry"},{"issue":"3","key":"1810_CR60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/00048670903487118","volume":"44","author":"N Korver","year":"2010","unstructured":"Korver N, Nieman DH, Becker HE, van de Fliert J, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH (2010) Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Aust N Z J Psychiatry 44(3):230\u2013236. https:\/\/doi.org\/10.3109\/00048670903487118","journal-title":"Aust N Z J Psychiatry"},{"issue":"suppl 1","key":"1810_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1751-7893.2012.00392.x","volume":"6","author":"A Lin","year":"2012","unstructured":"Lin A, Nelson B, Wood S, Beavan A, McGorry P, Yung A (2012) Outcomes of non-transitioned cases in a sample at ultra-high risk for psychosis: a medium to long-term follow-up study. Early Interv Psychiatry 6(suppl 1):3. https:\/\/doi.org\/10.1111\/j.1751-7893.2012.00392.x","journal-title":"Early Interv Psychiatry"},{"key":"1810_CR62","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1016\/S0920-9964(14)70437-2","volume":"1","author":"M Pardo","year":"2014","unstructured":"Pardo M, Sintes A, Puig O, Espelt C, De La Serna E, Rodriguez M, Espadas M, Carulla M, Baeza I, Dolz M (2014) Cannabis use and neuropsychological functioning in ultra-high risk for developing psychosis in child and adolescent patients and healthy controls. Schizophr Res 1:S146","journal-title":"Schizophr Res"},{"issue":"6","key":"1810_CR63","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1046\/j.1440-1614.2002.01089.x","volume":"36","author":"LJ Phillips","year":"2002","unstructured":"Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD (2002) Cannabis use is not associated with the development of psychosis in an \u2018ultra\u2019 high-risk group. Aust N Z J Psychiatry 36(6):800\u2013806. https:\/\/doi.org\/10.1046\/j.1440-1614.2002.01089.x","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"1810_CR64","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/eip.12437","volume":"12","author":"HJ Stain","year":"2018","unstructured":"Stain HJ, Halpin SA, Baker AL, Startup M, Carr VJ, Schall U, Crittenden K, Clark V, Lewin TJ, Bucci S (2018) Impact of rurality and substance use on young people at ultra high risk for psychosis. Early Interv Psychiatry 12(6):1173\u20131180. https:\/\/doi.org\/10.1111\/eip.12437","journal-title":"Early Interv Psychiatry"},{"key":"1810_CR65","doi-asserted-by":"publisher","first-page":"S305","DOI":"10.1093\/schbul\/sbt011","volume":"1","author":"J Stowkowy","year":"2013","unstructured":"Stowkowy J, Addington J (2013) Predictors of developing a psychosis risk syndrome in youth at family high risk of developing psychosis. Schizophr Bull 1:S305. https:\/\/doi.org\/10.1093\/schbul\/sbt011","journal-title":"Schizophr Bull"},{"key":"1810_CR66","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291719001077","author":"OA Ayonrinde","year":"2019","unstructured":"Ayonrinde OA (2019) Cannabis and psychosis: revisiting a nineteenth century study of \u2018Indian Hemp and Insanity\u2019 in Colonial British India. Psychol Med. https:\/\/doi.org\/10.1017\/s0033291719001077","journal-title":"Psychol Med"},{"issue":"5","key":"1810_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/1748895811415345","volume":"11","author":"AD Hathaway","year":"2011","unstructured":"Hathaway AD, Comeau NC, Erickson PG (2011) Cannabis normalization and stigma: contemporary practices of moral regulation. Criminol Crim Justice 11(5):451\u2013469. https:\/\/doi.org\/10.1177\/1748895811415345","journal-title":"Criminol Crim Justice"},{"issue":"4","key":"1810_CR68","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/003803850203600408","volume":"36","author":"H Parker","year":"2002","unstructured":"Parker H, Williams L, Aldridge J (2002) The normalization of \u2018sensible\u2019 recreational drug use: further evidence from the North West England longitudinal study. Sociology 36(4):941\u2013964. https:\/\/doi.org\/10.1177\/003803850203600408","journal-title":"Sociology"},{"issue":"3 Pt 1","key":"1810_CR69","first-page":"193","volume":"29","author":"S Potvin","year":"2003","unstructured":"Potvin S, Stip E, Roy JY (2003) Schizophrenia and addiction: an evaluation of the self-medication hypothesis. Encephale 29(3 Pt 1):193\u2013203","journal-title":"Encephale"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-019-01810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00127-019-01810-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-019-01810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T19:59:38Z","timestamp":1606852778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00127-019-01810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1007\/s00127-019-01810-x","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}